SCHEMBL7546697

SCHEMBL7546697

COc1cccc(-c2cncc(-c3cn(CCCN(C)C)c4ccc(Cl)cc34)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.53
GSK3B P49841 4/20 0.44
PRKCA P17252 2/20 0.44
PRKD1 Q15139 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
QPCT Q16769 2/20 0.41
ICMT O60725 2/20 0.40
PRKCB P05771 1/20 0.39
PRKCE Q02156 1/20 0.39
FLT3 P36888 1/20 0.39
HTR6 P50406 2/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
PIK3CA P42336 1/20 0.37
MTOR P42345 1/20 0.37
PIK3CG P48736 1/20 0.37
BCHE P06276 1/20 0.37
MAT2A P31153 1/20 0.37
BRD4 O60885 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7991002 0.93 KDR (0.53) KDRGSK3BPRKCAPRKD1TDP1
SCHEMBL7993991 0.93 KDR (0.53) KDRGSK3BPRKCAPRKD1TDP1
SCHEMBL7987071 0.93 KDR (0.56) KDRGSK3BPRKD1TDP1QPCT
SCHEMBL7987952 0.91 KDR (0.58) KDRPRKCAICMTPRKCBPRKCE
SCHEMBL7990591 0.90 KDR (0.53) KDRGSK3BPRKCAPRKD1TDP1
SCHEMBL7550679 0.89 KDR (0.67) KDRGSK3BPRKCAPRKD1TDP1
SCHEMBL7986701 0.88 KDR (0.53) KDRGSK3BPRKD1TDP1QPCT
SCHEMBL7554248 0.88 KDR (0.62) KDRPRKCAPRKD1TDP1PRKCB
SCHEMBL7990759 0.87 KDR (0.51) KDRGSK3BPRKD1TDP1QPCT
SCHEMBL7512866 0.86 KDR (0.60) KDRGSK3BPRKD1TDP1QPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed